If conventional treatments for restless legs syndrome have stopped working, medical cannabis may help. LeafEase specialist clinicians can assess your suitability privately and online.
Restless Legs Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological condition that causes an uncontrollable urge to move the legs, typically triggered by uncomfortable sensations such as tingling, aching, or crawling feelings. Symptoms are usually worst during periods of rest and intensify in the evening and at night, making sleep difficult and daytime fatigue common.
RLS affects an estimated 5 to 10% of UK adults.¹ Conventional treatments include dopamine agonists, gabapentinoids, and sleep aids, but these can lose effectiveness over time or cause significant side effects.
Symptoms usually appear during periods of inactivity and may worsen in the evening or at night. Common symptoms include:
If these symptoms are familiar and persist despite standard treatments, you can explore RLS medical cannabis treatment in the UK through a simple online eligibility check at LeafEase, which results in minutes.
Restless leg syndrome is closely linked to abnormalities in how the brain processes dopamine a neurotransmitter responsible for regulating muscle movement and sensory signals. When dopamine signalling is disrupted, it can trigger the uncomfortable sensations and involuntary movement urges that define the condition.
A range of factors may contribute to RLS, including neurological changes, iron deficiency, underlying health conditions such as chronic kidney disease or peripheral neuropathy, and genetic predisposition.
Common causes include:
In some individuals, symptoms appear without a clear cause, while in others they may be linked to iron deficiency or nerve-related conditions.
In the UK, treatment for restless leg syndrome typically begins with lifestyle changes such as improving sleep routines, reducing caffeine intake, and increasing physical activity. Where symptoms remain persistent, clinicians may prescribe medications aimed at regulating dopamine pathways and improving sleep quality.
When standard treatments fall short, medical cannabis can help manage restless legs syndrome under clinical supervision. At LeafEase, patients undergo a structured assessment to determine suitability, with ongoing monitoring to ensure treatment remains safe and effective over time.
Yes. Medical cannabis for restless legs syndrome can be legally prescribed in the UK through a specialist private clinic when conventional treatments have not provided sufficient relief.
Medical cannabis has been legal to prescribe in the UK since November 2018.² It is not available on the NHS for RLS but can be accessed through CQC-regulated clinics like LeafEase following a clinical prescription. THC may help reduce the characteristic discomfort associated with restless legs and promote muscle relaxation, while CBD may help address underlying inflammation and improve sleep quality.³
Important: RLS medical cannabis treatment is not a first-line option. To be considered eligible, you will typically need a confirmed diagnosis and documented evidence that conventional treatments have been trialled without adequate benefit.
Medical cannabis interacts with the endocannabinoid system, a regulatory network that governs nerve signalling, muscle activity, and sleep patterns throughout the body. Two primary cannabinoids, THC (tetrahydrocannabinol) and CBD (cannabidiol), influence how the nervous system processes discomfort and the urge to move.
THC may help modulate nerve-related sensations and support more restful sleep, while CBD contributes anti-inflammatory properties and helps stabilise nerve activity, both of which are relevant mechanisms in RLS symptom management.
In the UK, RLS medical cannabis treatment is only available through GMC-registered specialist prescribers. At LeafEase, all prescriptions are clinically overseen to ensure they are safe, regulated, and tailored to each patient’s profile.
Research into medical cannabis for restless legs syndrome is still emerging, but existing evidence points to meaningful potential for patients who have not responded to standard care.
Oral cannabis spray trial: A clinical trial found that patients with RLS experienced both short-term and sustained symptomatic improvement with an oral cannabis spray containing 2.7 mg THC and 2.5 mg CBD per dose, including reduction in the urge to move and associated discomfort.⁴
Shannon, S. et al. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 23:18–041.
UK Medical Cannabis Registry (2023): Patients prescribed CBMPs for chronic neurological pain conditions including RLS reported improvements in sleep quality, pain scores, and general wellbeing over a 12-month follow-up period.⁵
Active RCT (2025): A randomised placebo-controlled pilot trial is currently underway at Sunnybrook Health Sciences Centre evaluating the safety and efficacy of cannabis oil in RLS patients, with results expected in 2027.⁶
This is one of the most common questions our patients ask.
The key differences are:
CBD oil is an over-the-counter food supplement containing cannabidiol (CBD) only. It is not regulated as a medicine, and its contents and concentration are not subject to the same quality controls as prescription medicines. It is not the same as a medical cannabis prescription.
Medical cannabis is a prescribed, regulated medicine dispensed under a specialist’s direct clinical supervision. It may contain both THC and CBD in clinically determined ratios, and is typically significantly more potent than CBD supplements. It is only available via a valid prescription from a licensed specialist clinic.
For patients with moderate-to-severe anxiety who have not responded adequately to conventional treatments or over-the-counter CBD, prescribed medical cannabis is a clinically distinct and more carefully managed therapeutic option.
A 2019 case series found that CBD reduced anxiety scores in 79% of patients within the first month of treatment, with effects maintained at three months.
Your initial consultation is with a GMC-registered specialist clinician who will review your medical history, previous treatments, and current symptoms. Consultations are conducted online at a time that suits you.
If medical cannabis is appropriate for you, your clinician will determine the right formulation and starting dose. They will explain how to use your medication safely and what to expect.
Your prescription is dispatched discreetly to your home address in clearly labelled original packaging with your prescription details attached.
LeafEase provides regular follow-up appointments to review how you are responding to treatment. Your prescription can be adjusted as needed.
Medical cannabis is generally well tolerated when prescribed and monitored by specialist clinicians. Some patients may experience mild side effects in the early stages of treatment, which can vary depending on dosage, formulation, and individual response.
Possible side effects include:
Most side effects are temporary and tend to resolve as the treatment plan is reviewed and adjusted. All LeafEase patients are monitored at regular intervals to ensure their prescription remains clinically appropriate and safe.
As a medical cannabis patient in the UK,
You have specific legal rights that are important to know:
You can use your prescribed medication, typically via a dry herb vaporiser, in public spaces such as parks, streets, and open areas. In private venues, staff may ask you to use a designated area. For large events, contact the venue in advance.
You are legally entitled to take your medication at work as directed by your doctor. Speak to your employer in advance if your role involves driving, operating machinery, or if your contract references controlled substances.
You must not drive if impaired. If your prescription contains THC, you may test above the legal roadside limit — but you can use the medical defence under Section 5A(3) of the Road Traffic Act 1988 if you are not impaired and are taking your medication as prescribed.
You are legally permitted to use your prescription medication in your rented home. This is not affected by clauses prohibiting smoking.
Contact the UK embassy for your destination country well in advance of travel. Bring your prescription, prescription-labelled medication tub, and personal ID. Request a travel letter from your clinician.
Medical cannabis can help regulate nerve signalling and sleep patterns, which may reduce leg discomfort and improve sleep in some individuals with restless leg syndrome.
Yes. In the UK, GMC-registered specialists can legally prescribe medical cannabis for restless legs syndrome when conventional treatments haven’t provided enough relief. You’ll need a confirmed diagnosis and a record of treatments already tried. LeafEase online eligibility check reviews this in minutes.
Medical cannabis may help regulate sleep cycles and reduce nighttime discomfort associated with restless leg syndrome. By influencing nerve signalling and relaxation pathways, it can support improved sleep quality for some individuals.
Medical cannabis interacts with the body’s endocannabinoid system, which helps regulate nerve activity and sensory signals. This interaction can help reduce uncomfortable sensations such as tingling or crawling feelings in the legs.
At LeafEase, eligibility is determined through a specialist clinical assessment that reviews your symptoms, medical history, and previous treatments to evaluate whether regulated medical cannabis treatment may be appropriate for managing restless leg syndrome.
The evidence is still early and mixed. CBD is not a proven treatment for restless legs syndrome, and high-street CBD oil is sold as a food supplement rather than a regulated medicine, meaning strength and quality vary considerably between products. Prescription cannabis is different: it is clinically supervised, quality-controlled, and may include THC alongside CBD. If over-the-counter CBD has not helped, it is worth checking whether you qualify for a regulated prescription instead.
THC features in some of the more encouraging early clinical reports. A small open-label exploratory trial using an oral THC and CBD spray reported reduced urge to move and less leg discomfort in RLS patients, though the trial was limited in size, included mostly MS patients, and had no placebo group. That is a promising signal, not established proof, and larger controlled trials are still needed. In the UK, THC is only available through regulated prescription medicines and is never sold over the counter. A GMC-registered specialist assesses whether it may be appropriate for your situation.
Yes. In the UK, medical cannabis is considered when conventional treatments have not provided sufficient relief. You will typically need a confirmed RLS diagnosis and a record of at least two treatments already tried. LeafEase’s online eligibility check reviews your situation in minutes, with no obligation to proceed.
If cannabis for restless legs syndrome is something you want to explore, our clinical team will assess your suitability honestly and without pressure.
Find out if medical cannabis may be right for you — no GP referral needed.
1. Innes KE, et al. (2012). Prevalence of restless legs syndrome in North American and Western European populations. Sleep Medicine. 13(7):831-43.
2. UK Home Office (2018). Rescheduling of cannabis-based products for medicinal use in humans. gov.uk
3. CED Clinic (2026). Cannabis for RLS: Current Evidence and Clinical Caution. cedclinic.com
4. CED Clinic (2026). Oral Cannabis Spray Improves Restless Legs Syndrome. cedclinic.com
5. UK Medical Cannabis Registry (2023). Clinical outcomes of CBMP therapy for chronic neurological pain. Imperial College London / Curaleaf Clinic.
6. Sunnybrook Health Sciences Centre (2025). Using Cannabis to Treat Restless Legs Syndrome: A Randomized Placebo Controlled Pilot Safety and Feasibility Trial. ClinicalTrials.gov: NCT06863740.
Important notice: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified clinician before changing your treatment.
Regulatory note: Medical cannabis is a Schedule 2 controlled drug in the UK, prescribable only by a GMC-registered specialist. LeafEase is fully CQC-registered.
